GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are key contributors to rising prescription spending. That may ...

Cost advantages concentrated in higher OOP tiers: only 15% of all prescriptions were cheaper, but MCCPDC undercut insurance for ~82% of fills when OOP exceeded $15. Therapeutic areas with frequent ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

WASHINGTON - Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some ‍drugs including Pfizer and Bristol Myers Squibb's blood thinner Eliquis and Merck & Co's diabetes ...

In the U.S., the price of Revlimid, a brand-name cancer drug, has been increasing for two decades. It now sells for nearly $1,000 a pill. In Europe, the price has been consistently lower — in some ...

A new AARP report finds top brand-name medications increase sharply in the U.S., while prices for the same drugs drop or hold ...

(The Hill) — Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP. The study, published Thursday, found that the ...

The Trump administration will pursue similar prescription drug pricing deals to the one reached this past week with the United Kingdom with other countries that have not yet locked in trade agreements ...

President Donald Trump has said it plainly: Americans pay “massively higher prices than other nations pay for the same exact ...